MedTrace Logo

Clopidogrel/Aspirin Interaction Study

NCT01102439 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2015-04-28

No results posted yet for this study

Summary

This study will explore the effect of different doses of aspirin on the effects of double-dose or standard dose clopidogrel.

Conditions

Interventions

DRUG

Clopidogrel

300 mg loading dose, then 75 mg daily

DRUG

Clopidogrel

600 mg loading dose, 150 mg daily day 2-7, then 75 mg daily

DRUG

Aspirin

81 mg daily

DRUG

Aspirin

325 mg daily

Sponsors & Collaborators

  • Population Health Research Institute

    lead OTHER

Principal Investigators

  • Yan Liang, MD · Population Health Research Institute

  • John Eikelboom, MD. · Population Health Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2010-12-31
Completion
2013-02-28

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01102439 on ClinicalTrials.gov